Is neoadjuvant treatment indicated in triple negative cT1N0 breast cancer? Garcia-Torralba; Noel Blaya Boluda; María Esperanza Guirao García; Elisa García Garre; Francisco Ayala de la Peña;

PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy Hayam E. Rashed; Randa E. Monged; Nashwa Nawar; Ahmed Z. Alattar; Ahmed A. Alnagar; Mohamed I. Abdelhamid; Osama Abdelaziz; Nelly M. Said;

Diagnostic utility of PELP1 and GATA3 in primary and metastatic triple negative breast cancer Manar Moustafa; Magdy Ismael; Salah Mohamed; Abeer Magdy;